Stay updated with breaking news from Webs. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Emergent BioSolutions Inc. (NYSE:EBS – Get Free Report) was the recipient of unusually large options trading activity on Wednesday. Traders purchased 3,153 put options on the stock. This is an increase of 344% compared to the typical daily volume of 710 put options. Emergent BioSolutions Stock Performance Shares of NYSE:EBS traded up $0.03 on Wednesday, […]
Emergent BioSolutions Inc. (NYSE:EBS – Get Free Report) was the target of a significant drop in short interest in March. As of March 15th, there was short interest totalling 4,910,000 shares, a drop of 20.8% from the February 29th total of 6,200,000 shares. Based on an average trading volume of 3,000,000 shares, the short-interest ratio […]
Introduced in 2017, the Electoral Bond Scheme allowed people to make any amount of donation to political parties of their choice while maintaining anonymity.
Benchmark upgraded shares of Emergent BioSolutions (NYSE:EBS – Free Report) from a hold rating to a buy rating in a research report sent to investors on Thursday morning, MarketBeat reports. They currently have $5.00 price objective on the biopharmaceutical company’s stock. A number of other analysts have also issued reports on the stock. JPMorgan Chase […]
Emergent BioSolutions (NYSE:EBS – Get Free Report) is scheduled to post its quarterly earnings results on Monday, February 26th. Emergent BioSolutions (NYSE:EBS – Get Free Report) last posted its quarterly earnings data on Monday, December 11th. The biopharmaceutical company reported ($1.44) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.12) by […]